New York City: New drug to fight colon cancer. The New York Times reports that 18 people who tried the drug Dostarlimab completely recovered. The trial period of the drug was six months.
The experiment was performed at the Memorial Sloan Catering Cancer Center in New York. The experiments were performed on people who had been diagnosed with early cancer and who had not been diagnosed with the disease in other organs.
Dosterlimab, which contains antibodies, wipes out cancer without side effects. All tests, including cancer tomography, PET scan, and MRI scan, showed complete cured.
This is the first time in the history of cancer treatment that this has happened successfully, said Dr. John H. Snyder, an oncologist at the University of California, Berkeley. Alan P. Wenok.
The disadvantage is that the test was performed on a very small number of patients and the diagnosis was not made after a careful microscopic examination of the cells. However, it is hoped that the results of the current experiments will change the level of the disease at the gene level.
